Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016)
Amarin Corp Plc\Uk (AMRN) posted quarterly Deferred Taxes of $11.9 million for Q4 2016, up 260.35% year-over-year from $3.3 million in Q1 2016, and up 1026.4% quarter-over-quarter from -$1.3 million in Q3 2016.
Amarin Corp Plcuk (AMRN) Deferred Taxes (2013 - 2016) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Deferred Taxes for 4 consecutive years, with $11.9 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Deferred Taxes rose 260.35% year-over-year to $11.9 million; the TTM figure through Dec 2016 stood at $8.8 million (up 197.51% YoY), while the FY2019 annual figure was $1.8 million, up 132.7% from the prior year.
- Deferred Taxes improved to $11.9 million in Q4 2016 per AMRN's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $11.9 million in Q4 2016 and bottomed at -$26.7 million in Q4 2013.
- Historically, Deferred Taxes has averaged -$2.3 million across 4 years, with a median of -$869000.0 in 2013.
- Annual changes were most pronounced in 2015 — Deferred Taxes sank 2151.61% — and 2016, when it jumped 260.35%.
- Amarin Corp Plc\Uk's Deferred Taxes stood at -$26.7 million in 2013, then surged by 85.89% to -$3.8 million in 2014, then plunged by 97.32% to -$7.4 million in 2015, then surged by 260.35% to $11.9 million in 2016.
- Business Quant data shows AMRN's Deferred Taxes at $11.9 million in Q4 2016, -$1.3 million in Q3 2016, and -$1.4 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.71 Bn | 632.95 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 469.97 Bn | 463.40 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 375.96 Bn | 368.82 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 304.06 Bn | 296.37 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 252.88 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.52 Bn | 222.53 Bn | 7.24 Bn | -291.00 Mn |
| 7 | Gilead Sciences | 182.20 Bn | 179.02 Bn | 6.22 Bn | -587.00 Mn |
| 8 | Pfizer | 159.49 Bn | 147.79 Bn | 10.94 Bn | -1.32 Bn |
| 9 | Gsk | 106.34 Bn | 102.17 Bn | 8.24 Bn | - |
| 10 | Amarin Corp Plcuk | 5.87 Bn | 5.56 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 11.93 Mn |
| Sep 30, 2016 | -1.29 Mn |
| Jun 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -446,000.00 |
| Dec 31, 2015 | -7.44 Mn |
| Sep 30, 2015 | -851,000.00 |
| Jun 30, 2015 | -636,000.00 |
| Mar 31, 2015 | -95,000.00 |
| Dec 31, 2014 | -3.77 Mn |
| Sep 30, 2014 | 75,000.00 |
| Jun 30, 2014 | 31,000.00 |
| Mar 31, 2014 | -24,000.00 |
| Dec 31, 2013 | -26.72 Mn |
| Sep 30, 2013 | -1.55 Mn |
| Jun 30, 2013 | -887,000.00 |
| Mar 31, 2013 | -3.95 Mn |